0.80Open1.01Pre Close308 Volume796 Open Interest145.00Strike Price32.78KTurnover30.40%IV2.02%PremiumJul 12, 2024Expiry Date0.00Intrinsic Value100Multiplier3DDays to Expiry0.96Extrinsic Value100Contract SizeAmericanOptions Type0.3427Delta0.0839Gamma145.25Leverage Ratio-0.2374Theta0.0049Rho49.78Eff Leverage0.0529Vega
Novo-Nordisk A/S Stock Discussion
France’s left-wing New Popular Front coalition unexpectedly blocked a far-right advance in the parliamentary run-off vote, securing the largest number of seats but falling short of an absolute majority. Estimates projected the coalition to win between 180 and 215 seats, while President Macron’s Ensemble party was set to secure 150 to 180 seats and the far-right Rassemblement National 120 to 150 seats. No party achieved the 289 seats needed f...
$S&P 500 Index(.SPX.US)$ $CBOE Volatility S&P 500 Index(.VIX.US)$ $Nasdaq Composite Index(.IXIC.US)$ $Dow Jones Industrial Average(.DJI.US)$ $Novo-Nordisk A/S(NVO.US)$ $Crude Oil Futures(AUG4)(CLmain.US)$
Among individual stocks, $Tesla(TSLA.US)$ surged on a deliveries beat while $Amazon(AMZN.US)$ rose following a bullish call. $Eli Lilly and Co(LLY.US)$ and $Novo-Nordisk A/S(NVO.US)$ fell on the stock market today after being cri...
The phase 3 CLARION-CKD trial, which investigated ocedurenone in patients with uncontrolled hypertension and advanced chronic kidney disease, was conducted by KBP Biosciences, a company acqu...
No comment yet